# Mind-NRG

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mind-nrg

- Industry: Pharmaceuticals
- Headquarters: Geneva, Switzerland
- Website: www.mind-nrg.com
- Total disclosed funding: $11M
- Latest round: Series B (Sep 4, 2013)
- Investors on record: 2

## About

Founded in 2010, based in Switzerland, Mind-NRG is focused on the development of neurological and psychiatric disorders. NRG-101 is a neurotrophic factor with disease modifying potential that naturally crosses the blood - brain barrier through a receptor-mediated transport to reach its target in the brain.

## Funding rounds

- Series B, Sep 4, 2013, $8M — Index Ventures, LRM
- Series A, Jan 11, 2011, $0.5M — Index Ventures
- Series A, Oct 27, 2010, $2.1M — Index Ventures

## Investors

- Index Ventures (https://capitalatlas.ai/funds/index-ventures) — Series A, Series B
- LRM (https://capitalatlas.ai/funds/lrm) — Series B